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Chronic elevated levels of particulate   matter 
(PM) air pollution and long-term residential 
exposure to high traffic levels both increase car-
diovascular morbidity and mortality (Beelen 
et al. 2008; Brook et al. 2004; Miller et al. 
2007; Rosenlund et al. 2006). In animal experi-
ments, long-term exposure to high PM induces 
the development and progression of athero-
sclerosis, the major underlying pathology for 
cardiovascular disease (Sun et al. 2005), with 
stronger effects seen for traffic-related ultrafine 
particles (UFPs) (Araujo et al. 2008). Initial 
epidemiologic evidence indicates an association 
between air pollution and traffic and atheroscle-
rosis in humans as well (Diez Roux et al. 2008; 
Hoffmann et al. 2007; Künzli et al. 2005).
Uncertainty exists about the mechanisms 
involved in the association between long-
term exposure to PM and atherosclerosis. 
Development and progression of atherosclero-
sis are strongly linked to inflammatory mecha-
nisms (Libby 2002). Plausible mechanisms 
for the effect of air pollution on atherogenesis 
include the induction of low-grade pulmo-
nary inflammation with a secondary systemic 
inflammatory response. Alveolar macrophages 
and bronchial epithelial cells exposed to PM 
release increased quantities of cytokines and 
chemo  kines (van Eeden et al. 2001), which 
enter the systemic circulation and stimulate 
the production of acute-phase proteins such 
as C-reactive protein (CRP) and fibrinogen 
in the liver. High levels of high-sensitivity 
(hs)-CRP and fibrinogen are independent pre-
dictors of cardiovascular disease (Fibrinogen 
Studies Collaboration 2007; Ridker and 
Morrow 2003) and may also act as mediators 
in the pathogenesis of atherosclerosis due to 
air pollution (Suwa et al. 2002). It has been 
shown that increased levels of CRP result-
ing from exposure to PM are involved in the 
infiltration of monocytes into the arterial wall 
(Yatera et al. 2008), which promotes athero-
genesis by amplifying inflammatory and pro-
coagulant responses (Libby 2002).
There is only limited epidemiologic evi-
dence for the association between PM and 
systemic inflammatory markers in the general 
population. Some investigators have observed 
associations between short-term increases in PM 
and CRP or fibrinogen (Pekkanen et al. 2000; 
Schwartz 2001), whereas others have found no 
consistent or only weak associations (Baccarelli 
et al. 2007a; Diez Roux et al. 2006; Liao et al. 
2005; Steinvil et al. 2008) or associations lim-
ited to selected populations (Dubowsky et al. 
2006; Peters et al. 2001; Rückerl et al. 2007; 
Seaton et al. 1999; Yue et al. 2007). A few stud-
ies so far have shown evidence for associations 
between medium- or long-term PM exposure 
(weeks to months) and inflammatory markers 
suggesting a sustained inflammatory response 
due to continuously or repeatedly elevated PM 
(Chen and Schwartz 2008; Diez Roux et al. 
2006; Zeka et al. 2006), whereas others did not 
find an association (Forbes et al. 2009).
In this study, we examined whether long-
term residential exposure to high levels of urban 
air pollution is associated with hs-CRP and 
fibrinogen, two systemic inflammatory markers, 
independent of short-term changes in air pollu-
tion and meteorology. We make use of a well-
examined population-based cohort located in a 
highly industrialized area of Western Germany.
Materials and Methods
Study design. We used baseline data from the 
Heinz Nixdorf Recall Study, an ongoing popu-
lation-based, prospective cardiovascular cohort 
study that started in 2000 and includes 4,814 
randomly selected participants 45–75 years of 
age from three large adjacent German cities 
(Essen, Mülheim, and Bochum) of the densely 
populated and highly industrialized Ruhr area. 
The study design has been described in detail 
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Ba c k g r o u n d: Long-term exposure to urban air pollution may accelerate atherogenesis, but mecha-
nisms are still unclear. The induction of a low-grade systemic inflammatory state is a plausible 
mechanistic pathway.
oBjectives: We analyzed the association of residential long-term exposure to particulate matter 
(PM) and high traffic with systemic inflammatory markers.
Me t h o d s : We used baseline data from the German Heinz Nixdorf Recall Study, a population-
based, prospective cohort study of 4,814 participants that started in 2000. Fine PM [aerodynamic 
diameter ≤ 2.5 µm (PM2.5)] exposure based on a small-scale dispersion and chemistry transport 
model was assigned to each home address. We calculated distances between residences and major 
roads. Long-term exposure to air pollution (annual PM2.5 and distance to high traffic) and concentra-
tion of inflammatory markers [high-sensitivity C-reactive protein (hs-CRP) and fibrinogen] on the 
day of the baseline visit were analyzed with sex-stratified multiple linear regression, controlling for 
individual-level risk factors.
re s u l t s: In the adjusted analysis, a cross-sectional exposure difference of 3.91 µg/m3 in PM2.5 
(interdecile range) was associated with increases in hs-CRP of 23.9% [95% confidence interval (CI), 
4.1 to 47.4%] and fibrinogen of 3.9% (95% CI, 0.3 to 7.7%) in men, whereas we found no associa-
tion in women. Chronic traffic exposure was not associated with inflammatory markers. Short-term 
exposures to air pollutants and temperature did not influence the results markedly.
co n c l u s i o n s: Our study indicates that long-term residential exposure to high levels of PM2.5 is 
associated with systemic inflammatory markers in men. This might provide a link between air pollu-
tion and coronary atherosclerosis.
key w o r d s : air quality, cardiovascular disease, epidemiology, inflammation, roadway proximity. 
Environ Health Perspect 117:1302–1308 (2009).  doi:10.1289/ehp.0800362 available via http://
dx.doi.org/ [Online 11 May 2009]Long-term air pollution and inflammation
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 8 | August 2009  1303
elsewhere (Schmermund et al. 2002). It was 
approved by the relevant institutional ethics 
committees and follows strict internal and 
external quality assurance protocols. All study 
participants gave informed consent before the 
examinations. The baseline assessment included 
a self-administered questionnaire, face-to-face 
interviews for personal risk factor assessment, 
blood pressure measurements, anthropometric 
measurements, and comprehensive clinical and 
laboratory tests according to standard protocols.
Exposure assessment. The study area cov-
ers a region of approximately 600 km2. We 
used the EURAD (European Air Pollution 
Dispersion) model, a dispersion and chemis-
try transport model (Memmesheimer et al. 
2004) to estimate the annual mean values 
for background PM2.5 (aerodynamic diam-
eter ≤ 2.5 µm) concentrations (year 2002) 
on a spatial scale of 5-km grid-cell length and 
assigned these to the addresses of the partici-
pants (ArcGIS software; ESRI, Redlands, 
CA, USA). The EURAD model uses input 
data from official emission inventories on a 
scale of 1 km2, including industrial sources, 
household heating, traffic, and agriculture 
data on hourly meteorology and regional 
topography. Surface concentrations are cal-
culated by dispersing emissions in horizontal 
strata, taking chemical reactivity and trans-
port processes into account. From the model 
output, we calculated daily surface concentra-
tions of air pollutants for a grid-cell length of 
5 km and validated these by comparing the 
model-derived values with measured air pol-
lution data from monitoring sites (correlation 
between modeled daily averages of PM2.5 and 
measured PM2.5 was 0.86–0.88, depending on 
season) (Memmesheimer et al. 2004).
Daily means for PM and ozone from one 
central monitoring station representing the city-
wide background concentration of pollutants 
were received from the North Rhine-Westphalia 
State Agency for Nature, Environment and 
Consumer Protection [Landesamt fÜr Natur, 
Umwelt und Verbrasucherschutz (LANUV) 
NRW, Essen, Germany]. No routine PM2.5 
monitoring had been conducted in the Ruhr 
area during the study period, so we used PM10 
concentrations to assess daily exposures to PM. 
For 2000 through 2002, only data for total 
suspended particle (TSP) mass measurements 
were available, and were converted to PM10 
by multiplying by the factor of 0.85 for 2000 
and by 0.7 for 2001 and 2002, according to 
standard procedures (LANUV NRW). We set 
values less than the limit of detection (LOD; 
TSP, 10 µg/m3; ozone, 4 µg/m3) to LOD/2. 
Hourly temperature variables were obtained 
from the German National Meteorological 
Service (Deutscher Wetterdienst). For each 
individual blood draw, we assessed the daily 
means of PM10, ozone, and air temperature for 
the 5 days before the day of sampling.
We estimated residential exposure to traf-
fic by the distances between residence and 
major roads (freeways and federal highways), 
using administrative digitized maps based 
on compulsory surveying and mapping of all 
buildings with a precision of at least 0.5 m 
(MapInfo GmbH, Raunheim, Germany).
Markers of inflammation. As markers of 
inflammation, we measured high-sensitivity 
(hs)-CRP using an automated nephelometer 
(BN-II; Dade-Behring Inc., Deerfield, IL, 
USA) and fibrinogen in plasma with an auto-
mated BCS analyzer (Dade-Behring Inc.). All 
analyses were performed in the central labora-
tory of the University Hospital of Essen.
Socioeconomic status and lifestyle-related 
covariates. Socioeconomic status (SES) was 
assessed based on educational attainment as 
recommended by the German Epidemiological 
Association (Ahrens et al. 1998). We classi-
fied education according to the International 
Standard Classification of Education as 
total years of formal education, combining 
primary schooling and vocational or pro-
fessional education in one variable (United 
Nations Educational, Scientific, and Cultural 
Organization 1997). Four categories were 
defined with the highest category of ≥ 18 years 
of education (equivalent to a university degree) 
and the lowest category of ≤ 10 years (equiva-
lent to a basic school degree and no vocational 
training). Economic activity was included 
as employed, retired, unemployed, and eco-
nomically inactive (mostly homemakers). In a 
subgroup with information on income, we cal-
culated equivalent monthly household income 
by dividing total net household income by 
weighted number of household members.
Smoking status was categorized as current 
daily smoker, current occasional smoker, ces-
sation of smoking within last year, cessation of 
smoking more than one year ago, and never-
smoker. For current smokers, we assessed the 
number of smoked cigarettes per day. For 
current and ex-smokers, we also assessed the 
lifetime cumulative exposure in pack-years. 
We combined environmental tobacco smoke 
(ETS) at home, at the workplace, or in other 
places in one variable. Anthropometric 
measurements (height, weight, waist cir-
cumference) were conducted according to 
standardized protocols. Physical activity was 
assessed by converting daily activities and regu-
lar exercise into metabolic equivalents. Regular 
alcohol intake was defined as any alcohol con-
sumption at least 4–6 days per week.
We assessed personal characteristics that 
might have an effect-modifying role. Diabetes 
mellitus was defined as prior physician diagnosis 
of diabetes, taking an antidiabetic drug, having 
a blood glucose ≥ 200 mg/dL, or having a fast-
ing blood glucose ≥ 126 mg/dL. Coronary heart 
disease (CHD) was defined as a self-reported 
history of a myocardial infarction or coronary 
intervention. We defined current medication 
with cardiovascular or antiinflammatory drugs 
that could influence the concentration of 
inflammatory markers as any medication that 
includes statins, nonsteroidal antiinflamma-
tory drugs (NSAIDs), angiotensin-converting 
enzyme inhibitors (ACE inhibitors), or beta-
blockers (Casiglia and Tikhonoff 2007).
Statistical analysis. The entire study pop-
ulation consists of 4,814 participants. We 
performed analyses on a subgroup of the 
study population for whom measurements of 
inflammatory markers and complete infor-
mation on covariates were available (n = 
4,036). Participants with acute infections or 
acute exacerbations of inflammatory diseases 
(hs-CRP > 100 mg/L) were excluded from 
the analysis (n = 4), leaving 4,032 participants 
for the final analyses.
We used the Spearman correlation coeffi-
cient to examine the correlation between long-
term PM2.5 exposure and residential proximity 
to traffic and between daily apparent tempera-
ture and daily air pollutant concentrations.
To assess the association between long-
term measures of air pollution and inflamma-
tory markers, we performed multiple linear 
regression analyses with the natural logarithm 
of hs-CRP and fibrinogen as the dependent 
variables. We entered the annual mean PM2.5 
concentration on a continuous scale and 
categorized distance to roads in four classes: 
≤ 50 m, 51–100 m, 101–200, and > 200 m. 
PM2.5 effect estimates are given for the con-
centration difference between the 10th and 
the 90th percentile of the PM2.5 distribution 
(3.91 µg/m3). To investigate the linearity 
assumption of the relation and examine the 
exposure–response relationship, PM2.5 was 
classified according to quartiles of exposure 
(Q1, 21.54 µg/m3; Q2, 22.59 µg/m3; Q3, 
23.75 µg/m3) in separate analyses.
Because daily variations in PM concentra-
tions have been shown to exert a short-term 
effect on blood markers of inflammation 
(Seaton et al. 1999), we included the centrally 
measured PM10 concentration in a separate 
analysis. We averaged PM10 over the 5 days 
preceding the blood draw to account for the 
time needed to induce a systemic response 
with hepatic production of inflammatory 
markers and because prior studies have shown 
stronger associations for longer averaging times 
(Dubowsky et al. 2006; Yue et al. 2007; Zeka 
et al. 2006). Ozone concentration and mean 
air temperature were also entered, because they 
have been shown to influence inflammatory 
markers as well (Liao et al. 2005; Schneider 
et al. 2008). We determined average times 
(2-day for ozone and 5-day for temperature) 
based on model fit (R2). In models with short-
term exposures, we also added a variable for 
the long-term time trend and conducted analy-
ses stratified by season. Because of missing data Hoffman et al.
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on daily pollutant concentrations, analyses 
including daily pollutants were restricted to 
a subgroup of 1,752 men and 1,716 women. 
To ensure comparability of effect estimates, 
all effects are expressed per interdecile range of 
the exposure metric.
Although we based our analyses on cross-
sectional data that do not contain information 
about the temporal relations between studied 
variables, we used causal diagrams [directed 
acyclic graphs (DAGs)] to identify the mini-
mal sufficient adjustment set. Based on prior 
biological and epidemiological knowledge, 
we specified the most likely temporal rela-
tions between variables (Figure 1). According 
to this DAG, short-term PM exposure, SES, 
and area of residence need to be adjusted for 
(model 1). Because of the difficulties inher-
ent in adjusting for such a broad construct as 
SES, which increases the possibility of resid-
ual confounding, we additionally identified a 
sufficient adjustment set (model 2) that does 
not include SES but includes age, area of resi-
dence, and lifestyle-related factors [smoking 
behavior, ETS, body mass index (BMI), waist 
circumference, physical activity, alcohol con-
sumption, low-density lipoprotein (LDL), and 
high-density lipoprotein (HDL)]. We per-
formed analyses using both adjustment sets.
Based on prior results, we used subgroup 
analyses to assess effect measure modifica-
tion by age (< 60, ≥ 60 years), smoking status 
(regular current smokers, no regular current 
smoking), BMI (< 30 kg/m2, ≥ 30 kg/m2), 
diabetes, CHD, and intake of cardiovascular 
or antiinflammatory medication.
Sensitivity analyses. We investigated the 
sensitivity of our results to alternative ways of 
modeling by (a) performing a multiple logistic 
regression analysis with hs-CRP and fibrinogen 
dichotomized according to the 90th percen-
tile of their respective distributions (6.8 mg/L 
for hs-CRP and 438 mg/dL for fibrinogen); 
(b) using different lags and averaging times 
for recent exposure to PM10, ozone, and tem-
perature (lags 1–5, averaging times to include 
the prior 2–5 days); and (c) analyzing whether 
the observed associations were stronger in 
participants who had not been working full 
time during the last year before the baseline 
analysis and therefore presumably had spent 
more time at home. We also explored the pos-
sible effects of medication use and comorbidi-
ties as well as the sensitivity of the results to 
the exclusion of area and city of residence as 
confounders, because adjusting for area might 
remove some of the effect of the spatially dis-
tributed long-term exposure.
Results
Figure 2 illustrates the study region and loca-
tions of the participants’ residences. The study 
region includes areas with neighborhoods 
of multiunit residential apartment blocks 
transected by major highways, sub  urban neigh-
borhoods of mainly single- and double-unit 
houses, and rural areas in the south. Because 
of the strict definition of major road (freeways 
and federal highways), only about 15% of all 
participants lived within 50 m of a major 
road, which had mean daily vehicle counts 
of 10,000–130,000. Mean annual PM2.5 
concentration modeled on a 5-km grid-cell 
length (year 2002) was 22.8 µg/m3 (range, 
19.8–26.8 µg/m3) (Figure 3).
Markers of long-term exposure (annual 
mean PM2.5 and residential proximity to high 
traffic) were not correlated (Spearman cor-
relation coefficient = 0.01). Daily ozone con-
centration and apparent temperature were 
moderately correlated with each other, but 
not with daily PM10 (Table 1).
Table 2 describes the statistics of the study 
population. Participants included in the main 
analysis (n = 4,032) did not differ systemati-
cally from those excluded (n = 782) regarding 
exposure and personal characteristics (data 
not shown).
In the complete study group, we observed 
an association of PM2.5 with the inflamma-
tory mediators hs-CRP and fibrinogen. In 
the crude analysis and in the adjusted mod-
els 1 and 2, a 3.91 µg/m3 increase in PM2.5 
was associated with an increase in hs-CRP of 
16.7% [95% confidence interval (CI), 6.8 to 
27.5%], 14.0% (95% CI, 0 to 30.0%), and 
10% (95% CI, –2.6 to 24.3%), respectively. 
Using the same models, PM2.5 was associated 
Figure 1. Causal diagram for the investigation of 
the relationship of residential air pollution exposure 
with inflammatory markers.
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Figure 2. Study region of the Heinz Nixdorf Recall Study: annual PM2.5 values for the year 2002. 
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Figure 3. Distribution of modeled annual air pollution exposure (year 2002) and residential distance to 
major roads for 4,032 participants of the Heinz Nixdorf Recall Study.
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with an increase in fibrinogen of 2.4% (95% 
CI, 0.6 to 4.2%), 3.69% (95% CI, 1.0 to 
6.4%), and 2.7% (95% CI, 0.1 to 5.3%), 
respectively.
Table 3 displays the sex-stratified results. 
For men, effect estimates in the crude and the 
two adjusted models (models 1 and 2) were 
very similar, yielding a 24% increase in hs-
CRP and a 4% increase in fibrinogen. Within 
the relatively small range of PM2.5 exposures 
in our study region, we did not find a positive 
exposure–response relationship, but all point 
estimates for the upper three quartiles of expo-
sure were similarly elevated compared with the 
reference category of the lowest quartile.
In contrast to the findings in men, we 
found no consistent association of PM2.5 with 
inflammatory markers in women. We also 
observed no association between traffic expo-
sure and systemic inflammatory markers in 
both men and women.
Including daily centrally measured air pol-
lutants and apparent temperature attenuated the 
estimates for long-term exposure in men slightly 
(Table 4). Daily PM10 averaged over the 5 days 
preceding the blood draw was not associated 
with inflammatory markers. However, average 
ozone concentration and mean temperature 
during the 5 previous days were both associated 
with hs-CRP and fibrinogen.
For the association of long-term PM2.5 
with inflammatory markers, we observed 
no distinct differences in effect size among 
subgroups defined by age, smoking status, 
BMI, diabetes, CHD, and current medica-
tion because CIs overlapped considerably 
(Table 5). However, in men, effect estimates 
were higher in older subjects, nonsmokers, 
and nonobese subjects for both hs-CRP and 
fibrinogen. In women, nonobese, diabetic 
subjects, and subjects with higher education 
showed higher estimates for PM2.5.
In the logistic regression model, long-term 
average PM2.5 was weakly associated with 
high levels (> 90th percentile) of hs-CRP and 
fibrinogen in men [crude odds ratio for cross-
sectional difference of 3.91 µg/m3 PM2.5, 
1.45 (95% CI, 0.99 to 2.12) for hs-CRP and 
1.63 (95% CI, 1.11 to 2.41) for fibrinogen; 
adjusted odds ratio (model 2), 1.45 (95% CI, 
0.80 to 2.64) for hs-CRP and 2.06 (95% CI, 
1.12 to 3.78) for fibrinoge]. We found no 
associations with dichotomized inflamma-
tory markers in women. Using different lags 
and averaging times for recent exposure to 
PM10, ozone, and temperature had no influ-
ence on the long-term PM2.5 estimate. Recent 
centrally measured PM10 was not associated 
with the inflammatory markers; however, 
we observed significant associations of recent 
ozone concentrations and apparent tempera-
ture with hs-CRP and fibrinogen.
In line with the hypothesis that effects 
of residential exposures should be stronger 
in subjects who presumably had spent more 
time at home before the baseline examina-
tion (smaller exposure estimation error), 
long-term PM2.5 was associated with inflam-
matory markers in men who had not been 
working within the past year, compared with 
subjects having worked any full-time job dur-
ing this period [model 2, 48.0% (95% CI, 
13.3 to 93.4%) vs. 12.2% (95% CI, –10.8 
to 41.1%) increase in hs-CRP; 6.5% (95% 
CI, 0.7 to 12.7%) vs. 2.5% (95% CI, –2.2 
to 7.4%) increase in fibrinogen]. In women, 
we observed no consistent pattern regarding 
time spent at home. This was also true for 
residential traffic exposure and inflammatory 
markers, both in men and in women.
Including covariates for current medi-
cation with lipid-lowering drugs, statins, 
NSAIDs, and a combined variable and cova-
riates for comorbidities (CHD, diabetes mel-
litus, hypertension, chronic obstructive lung 
disease, and arthritis) did not substantially 
influence the long-term PM2.5 estimates. 
Excluding city and area of residence from the 
models decreased the estimates in men [model 
1, 21.7% (95% CI, 7.6 to 37.7%) increase in 
hs-CRP and 2.64% (95% CI, 0.1to 5.2%) 
increase in fibrinogen; model 2, 14.0% (95% 
Table 2. Descriptive statistics of the study population (n = 4,032).
    Totala  Men  Women
   ( n = 4,032)  (n = 2,028)  (n = 2,004)
Age [years (mean ± SD)]  60.0 ± 7.8  60.1 ± 7.7  59.9 ± 7.8
Proximity to major road [n (%)]
  > 200 m  3,481 (84.8)  1,716 (84.6)  1,702 (84.9)
  > 100–200 m  297 (7.4)  152 (7.5)  145 (7.2)
  > 50–100 m  189 (4.7)  95 (4.7)  94 (4.7)
  ≤ 50 m  128 (3.2)  65 (3.2)  63 (3.1)
City [n (%)]
  Mülheim  1,501 (37.2)  759 (37.4)  742 (37.0)
  Essen  1,338 (33.2)  655 (32.3)  683 (34.1)
  Bochum  1,193 (29.6)  614 (30.3)  579 (28.9)
Area of residence [n (%)]
  North  562 (13.9)  275 (13.6)  287 (14.3)
  Central  2,272 (56.4)  1,172 (57.8)  110 (54.9)
  South  1,198 (29.7)  581 (28.7)  617 (30.8)
Educational level [n (%)]
  ≤ 10 years  415 (10.3)  96 (4.7)  319 (15.9)
  11–13 years  2,243 (55.6)  941 (46.4)  1,302 (65.0)
  14–17 years  928 (23.0)  700 (34.5)  228 (11.4)
  ≥ 18 years  446 (11.1)  291 (14.4)  155 (7.7)
Economic activity [n (%)]
  Employed  1,659 (41.2)  982 (48.4)  677 (33.8)
  Inactive, homemaker  541 (13.4)  8 (0.4)  533 (26.6)
  Retired  1,585 (39.3)  929 (45.8)  656 (32.7)
  Unemployed  247 (6.1)  109 (5.4)  138 (6.9)
Smoking status [n (%)]
  Daily smoker  825 (20.5)  432 (21.3)  393 (19.6)
  Occasional smoker  104 (2.6)  67 (3.3)  37 (1.9)
  Ex-smoker, ≤ 1 year  73 (1.8)  46 (2.3)  27 (1.4)
  Ex-smoker, > 1 year  1,359 (33.7)  915 (45.1)  444 (22.2)
  Never-smoker  1,671 (41.4)  568 (28.0)  1,103 (55.0)
ETS [n (%)]  1,308 (32.4)  697 (34.4)  611 (30.5)
BMI [kg/m2 (mean ± SD)]  27.9 ± 4.6  28.2 ± 3.9  27.7 ± 5.2
Waist circumference [cm (mean ± SD)]  94.4 ± 13.1  100.2 ± 10.7  88.5 ± 12.8
Weekly physical activity [n (%)]  2,057 (51.0)  1,044 (51.5)  1,013 (50.6)
Regular alcohol intake [n (%)]  819 (20.3)  605 (29.8)  214 (10.7)
Diabetes mellitus [n (%)]  555 (13.8)  363 (17.9)  192 (9.6)
CHD [n (%)]  270 (6.7)  216 (10.7)  54 (2.7)
Any antiinflammatory drugs [n (%)]b  1,629 (40.4)  852 (42.0)  777 (38.8)
Total cholesterol [mg/dL (mean ± SD)]  229 ± 39  224 ± 38  233 ± 40
Hs-CRP [mg/L, median (interquartile range)]  1.50 (2.50)  1.50 (2.40)  1.50 (2.50)
Fibrinogen [mg/dL, median (interquartile range)]  324 (97)  317 (95)  332 (98)
aExcludes participants with incomplete data on outcome or explanatory variables (782). bIncludes statins, NSAIDs, 
angiotensin-converting enzyme inhibitors, and beta-blockers.
Table 1. Description of centrally measured daily air pollutant concentrations and mean temperature for the 
period of the baseline analysis of the Heinz Nixdorf Recall Study (December 2000–July 2003).
  Correlation coefficient
  No.  Mean ± SD  Minimum  Maximum  Mean temperature  Ozone
Daily PM10 (µg/m3)  803  37.7 ± 19.7  5.0  147.0  0.04  –0.12
Daily ozone (µg/m3)  954  34.1 ± 21.5  2.0  111.0  0.60  —
Daily mean temperature (°C)  971    0.3 ± 6.8  –8.7  26.8  —  —Hoffman et al.
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CI, 1.7 to 27.8%) increase in hs-CRP and 
1.6% (95% CI, –0.8 to 4.0%) increase in 
fibrinogen], whereas it had an inconsistent 
effect in women. We observed no qualitative 
change in the exposure–response relation.
Discussion
The key finding of our study is that long-term 
residential exposure to high levels of PM2.5 
but not residential exposure to high traffic is 
weakly associated with systemic inflammatory 
markers in men, independent of acute changes 
in air pollution or temperature. Higher esti-
mates in the subgroup of men with a presum-
ably smaller exposure estimation error support 
our findings. We observed no consistent asso-
ciations between levels of PM2.5 or residential 
traffic exposure and systemic inflammatory 
markers in women.
Our results indicate that, in men, chronic 
exposure to high levels of PM2.5 might induce 
a low-grade persistent systemic inflamma-
tory state, which is independent of short-term 
changes in air pollutants and temperature. 
This is a novel finding, because in most studies 
only acute effects of short-term PM increases, 
which might trigger an acute cardiovascular 
event, have been investigated (Delfino et al. 
2008; Dubowsky et al. 2006; Peters et al. 
2001; Rückerl et al. 2007; Seaton et al. 1999; 
Yue et al. 2007). However, inflammation also 
plays an important role in the chronic process 
of atherogenesis (Libby 2002). Environmental 
inhalation exposures such as smoking or reg-
ular exposure to biomass smoke have been 
shown to induce a chronic low-grade inflam-
matory state (Baccarelli et al. 2007b; Ray 
et al. 2006). Few studies so far have examined 
effects of medium- or long-term PM expo-
sures, showing weak associations with CRP 
(Diez Roux et al. 2006; Zeka et al. 2006) 
and white blood count (Chen and Schwartz 
2008). Our findings provide a possible expla-
nation for prior results indicating an asso-
ciation between long-term air pollution and 
subclinical markers of atherosclerosis (Diez 
Roux et al. 2008; Hoffmann et al. 2007; 
Künzli et al. 2005).
Remarkably, our results show a group dif-
ference between the lowest quartile of expo-
sure and the upper three quartiles, without a 
clear exposure–response relationship within 
the upper three quartiles of exposure. Besides 
our lack of power to identify a possibly exist-
ing linear exposure–response relationship, 
given the widely overlapping CIs, this could 
also be explained by biologic processes fol-
lowing a nonlinear saturation kinetic, similar 
to mechanisms associated with ETS exposure 
(Pechacek and Bapp 2004).
Although we observed associations of long-
term PM2.5 exposure with inflammatory mark-
ers, we did not find consistent associations of 
long-term exposure to high traffic with inflam-
matory markers. Urban background PM2.5, 
averaged in a grid cell of 25 km2, is dominated 
by larger and more stable fine PM, which has 
been shown to induce pulmonary inflamma-
tion with a secondary systemic inflammatory 
Table 3. Associations of long-term PM2.5 exposure and residential traffic exposure with markers of inflammation [% change (95% CI)].
    hs-CRP  Fibrinogen
  Crude model  Model 1a  Model 2b  Crude model  Model 1a  Model 2b
Men (n = 2,028)
  PM2.5 (per 3.91 µg/m3)  27.2 (12.2 to 44.1)  29.4 (7.3 to 56.1)  23.9 (4.1 to 47.4)  3.5 (0.9 to 6.1)  4.8 (0.9 to 8.8)  3.9 (0.3 to 7.7)
  PM2.5 by quartilesc 
  > Q1–Q2  24.6 (6.8 to 45.3)  21.8 (1.7 to 45.9)  19.4 (1.0 to 41.1)  4.0 (0.8 to 7.3)  2.7 (–0.9 to 6.5)  2.0 (–1.5 to 5.6)
  > Q2–Q3  13.6 (0.1 to 28.9)  17.2 (–2.4 to 40.8)  17.1 (–1.3 to 38.8)  1.4 (–1.1 to 4.1)  2.4 (–1.3 to 6.2)  2.8 (–0.8 to 6.4)
  > Q3  38.2 (19.8 to 59.4)  22.7 (0.7 to 49.3)  18.6 (–1.1 to 42.3)  5.4 (2.4 to 8.5)  4.1 (0.1 to 8.3)  3.7 (–0.1 to 7.7)
  Proximity to major roadd 
  > 100–200 m  21.1 (0.5 to 45.8)  16.5 (–3.1 to 40.0)  11.9 (–5.7 to 32.7)  1.6 (–2.1 to 5.5)  0.9 (–2.8 to 4.7)  0.5 (–3.0 to 4.1)
  > 50–100 m  5.9 (–16.0 to 33.5)  1.4 (–19.3 to 27.5)  –1.7 (–20.5 to 21.4)  0.6 (–4.0 to 5.4)  0.0 (–4.5 to 4.7)  –0.6 (–4.8 to 3.9)
  ≤ 50 m  20.2 (–9.0 to 58.6)  18.4 (–10.0 to 55.7)  2.9 (–20.0 to 32.7)  3.2 (–2.4 to 9.1)  3.2 (–2.3 to 9.0)  1.1 (–4.1 to 6.6)
Women (n = 2,004)
  PM2.5 (per 3.91 µg/m3)  6.6 (–5.9 to 20.8)  0.4 (–16.5 to 20.7)  –1.0 (–16.5 to 17.3)  1.2 (–1.3 to 3.8)  2.5 (–1.3 to 6.3)  1.5 (–1.9 to 5.1)
  PM2.5 by quartilesc
  > Q1–Q2  7.2 (–7.6 to 24.3)  7.2 (–11.0 to 29.1)  3.2 (–13.1 to 22.6)  2.1 (–0.9 to 5.1)  1.3 (–2.4 to 5.2)  0.7 (–2.8 to 4.3)
  > Q2–Q3  2.7 (–8.3 to 16.3)  6.9 (–10.5 to 27.8)  8.6 (–7.9 to 27.9)  0.6 (–1.9 to 3.1)  2.4 (–1.2 to 6.1)  2.0 (–1.4 to 5.5)
  > Q3  12.7 (–2.0 to 29.5)  2.0 (–15.1 to 22.6)  2.0 (–13.9 to 20.9)  2.4 (–0.5 to 5.2)  2.6 (–1.1 to 6.5)  1.7 (–1.8 to 5.3)
  Proximity to major roadd 
  > 100–200 m  8.6 (–9.7 to 30.7)  5.4 (–12.4 to 26.9)  7.2 (–9.6 to 27.0)  2.1 (–1.6 to 6.0)  1.7 (–2.0 to 5.5)  1.7 (–1.8 to 5.3)
  > 50–100 m  –2.6 (–22.4 to 22.2)  –6.0 (–25.0 to 17.7)  –14.4 (–30.5 to 5.4)  –4.3 (–8.5 to 0.1)  –4.7 (–8.9 to –0.3)  –6.1 (–10.0 to –2.0)
  ≤ 50 m  5.2 (–20.0 to 38.4)  –1.0 (–24.6 to 30.0)  –15.3 (–34.1 to 8.9)  2.2 (–3.3 to 7.9)  1.3 (–4.1 to 6.9)  –0.6 (–5.6 to 4.6)
aModel 1 represents the minimal sufficient adjustment set, including city and area of residence and SES variables (education and economic activity). bModel 2 represents the nonmini-
mal adjustment set without SES variables. Covariates are city and area of residence, age, smoking variables, ETS, physical activity, alcohol intake, BMI, waist circumference, LDL, and 
HDL. cLowest quartile used as reference. Q1, 21.54 µg/m3; Q2, 22.59 µg/m3; Q3, 23.75 µg/m3. d > 200 m used as reference. 
Table 4. Estimates for the association of modeled annual PM2.5, centrally measured daily air pollutants (PM10, ozone), and mean daily air temperature with inflam-
matory markers [% change (95% CI)].a
    hs-CRP  Fibrinogen
  Model 2  Model 2 plus daily exposures  Model 2  Model 2 plus daily exposures
Men (1,752)b 
  Annual PM2.5 (per 3.91 µg/m3)  23.7 (2.4 to 49.5)  19.4 (–1.1 to 44.2)  3.2 (–0.7 to 7.3)  2.2 (–1.7 to 6.2)
  5-day mean PM10 (per 31.85 µg/m3)  —  1.9 (–9.1 to 14.0)  —  –0.8 (–3.0 to 1.6)
  2-day mean ozone (per 55 µg/m3)  —  20.8 (1.7 to 43.6)  —  2.2 (–1.3 to 5.9)
  5-day mean temperature (per 16.98 °C)  —  –17.6 (–29.4 to –3.8)  —  –6.3 (–9.2 to –3.3)
Women (1,716)b
  Annual PM2.5 (per 3.91 µg/m3)  –0.7 (–17.4 to 19.4)  –2.0 (–18.5 to 17.9)  2.0 (–1.8 to 5.8)  2.2 (–1.5 to 6.1)
  5-day mean PM10 (per 31.85 µg/m3)  —  –7.1 (–17.1 to 4.0)  —  –1.4 (–3.6 to 0.1)
  2-day mean ozone (per 55 µg/m3)  —  28.1 (7.7 to 52.4)  —  2.4 (–1.1 to 6.1)
  5-day mean temperature (per 16.98°C)  —  –14.8 (–27.0 to –0.5)  —  –5.1 (–8.0 to –2.1)
aBased on a restricted sample of 1,752 men and 1,716 women because of missing data on daily exposure variables. bEstimates adjusted for city and area of residence, age, smoking vari-
ables, ETS, physical activity, alcohol intake, BMI, waist circumference, LDL, and HDL (model 2 from Table 3) and long-term time trend.Long-term air pollution and inflammation
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response (Frampton 2006). Residence close 
to a major road, however, leads to high expo-
sure with traffic-related, combustion-derived 
UFPs (< 100 nm) (Zhu et al. 2002). UFPs can 
escape pulmonary defense mechanisms because 
of their small size and might be able to trans-
locate into the systemic circulation (Elder and 
Oberdörster 2006), where they may directly 
access the endothelium and promote athero-
sclerosis (Yamawaki and Iwai 2006) without 
prior induction of a systemic inflammatory 
response. Furthermore, soluble components 
from PM such as metals or organic substances, 
originating to a high degree from traffic-related 
combustion, enter the systemic circulation, 
where they can act on the endothelium without 
inducing systemic inflammation (Wallenborn 
et al. 2007). Experimental evidence for the 
translocation of PM remains controversial, 
however, and exact knowledge about the cel-
lular and molecular mechanisms of a possible 
PM-induced chronic pulmonary inflammation 
with a secondary low-grade systemic inflamma-
tory state is still lacking. Other possible expla-
nations for our inability to observe an effect 
of residential traffic exposure include exposure 
misclassification by using only distance to a 
major road instead of actual traffic density in 
the vicinity of the residence.
We also found no association with short-
term PM10 exposure. Possible explanations 
include a) the low power of our cross-sectional 
study design to identify weak short-term 
effects, and b) misclassification of short-term 
exposures due to spatial variability of daily 
exposures within the study area.
Our findings suggest that the observed 
association is modified by several personal 
characteristics, the most obvious being the 
differences between men and women. 
Different sex-specific effects of air pollution 
with outcomes such as inflammatory markers 
and athero  sclerosis have also been reported 
by others (Künzli et al. 2005; Steinvil et al. 
2008). First, different exposure patterns and 
sources could explain some of the heterogene-
ity. Second, endogenous estrogen and post-
menopausal hormone replacement therapy 
have been shown to alter plasma levels of a 
variety of cytokines and inflammatory mark-
ers, possibly contributing to the observed 
effect modification (Störk et al. 2008; Wong 
et al. 2008). In our own study population, 
sex differences in the association of hs-CRP 
and coronary artery disease have recently been 
documented (Erbel et al. 2008).
In our highly industrialized study area 
with still ongoing coal mining and steel pro-
duction, men are more likely to be or have 
been employed in occupational settings with 
dusts and fumes, which might be indepen-
dently associated with these two inflammatory 
markers. Therefore, confounding by occupa-
tional exposure could be a concern. However, 
when stratifying according to broad categories 
of SES, we found higher effect estimates in 
highly educated men, who are less likely to 
work in jobs with dust exposure. Associations 
were also more pronounced in participants 
who were older, nonobese, or nonsmokers. 
Diabetes, CHD, and cardiovascular or anti-
inflammatory medication had no consistent 
influence on the effect estimates in men. 
In contrast to earlier findings in short-term 
exposure studies, we found no clear attenua-
tion of effects by intake of statins or any other 
cardio  vascular or antiinflammatory medica-
tion (Dubowsky et al. 2006).
Even though our effect estimates were gen-
erally inconsistent in women, we noted higher 
estimates in nonobese, highly educated, and 
diabetic subjects. The low precision of our 
estimates prohibit definite conclusions about 
factors that determine individual susceptibility; 
however, our findings warrant further investi-
gations of sex-specific mechanisms and other 
individual characteristics that may play a role 
in the induction of chronic inflammation.
Because identifying a minimal suffi-
cient adjustment set with the help of causal 
diagrams is strongly dependent on assump-
tions regarding the temporal and causal 
relations between variables, other multivari-
able models might be more adequate. We 
based our causal diagram on prior knowl-
edge. However, other causal relations could 
be possible, resulting in different adjustment 
sets. Also, residual confounding in the adjust-
ment for individual SES might be large. We 
therefore used two different approaches by 
adjusting for a nonminimal set of variables 
as well as excluding SES variables. Results 
for the long-term PM2.5 estimates were very 
similar, which strengthens our confidence in 
the applicability of the chosen DAG for the 
investigation of long-term urban background 
PM exposures.
In the analyses of residential proximity to 
major roads, estimates using the two differ-
ent adjustment sets differed substantially, with 
estimates for the SES adjustment set (model 1) 
being closer to the crude estimate and the 
estimates from model 2, comprising lifestyle 
related factors and age instead of SES variables, 
were usually closer to the null. This could point 
to an inadequately specified causal model for 
the assessment of effects due to very small-scale 
spatial variability in traffic exposure.
The major limitation of our study is the 
relatively small exposure contrast for PM2.5 
in our study population, caused by the degree 
of spatial resolution our current air quality 
model provides. In this analysis, we used a 
grid cell length of 5 km, resulting in cell sizes 
of 25 km2, which probably leads to substan-
tial exposure estimation error in this metro-
politan area. Future analyses with a higher 
spatial resolution of the air quality model will 
enable us to examine the size and effect of 
this potential source of exposure estimation 
error more closely. Moreover, our long-term 
exposure assessment is inhibited by a miss-
ing temporal resolution. We used the 2002 
annual PM2.5 average, regardless of the actual 
dates of the subjects’ baseline examinations. 
This exposure measure can lead to an error in 
the exposure assessment if yearly or monthly 
trends in exposure are different across the 
study region.
Major strengths of our study include 
the availability of measures of long-term as 
well as short-term exposure to ambient PM 
air pollution and the possibility to adjust for 
short-term changes in temperature and ozone 
exposure. Moreover, the geographically small 
and coherent study region probably provided 
a more similar mixture of PM constituents 
throughout the study region than in studies 
pooling data from regions further apart and 
where PM effects might be confounded by 
different compositions of the PM mixture. In 
addition, the large, population-based sample of 
well-  examined participants allowed extensive 
control of possible confounding covariates.
Table 5. Adjusted estimates (model 2) of subgroup analyses for PM2.5 exposure and inflammatory markers 
CRP and fibrinogen [% change (95% CI)].
  Men (n = 2,028)  Women (n = 2,004)
  hs-CRP  Fibrinogen  hs-CRP  Fibrinogen
Age < 60 years  17.7 (–8.4 to 51.2)  3.6 (–1.5 to 8.9)  10.4 (–13.6 to 41.0)  2.1 (–2.9 to 7.3)
Age ≥ 60 years  32.6 (3.8 to 69.4)  5.0 (–0.3 to 10.6)  –10.2 (–29.2 to 13.8)  1.1 (–3.7 to 6.2)
Low SES  15.5 (–9.7 to 47.8)  5.0 (–0.3 to 10.6)  –7.6 (–23.5 to –11.6)  0.0 (–3.9 to 3.9)
High SES  34.0 (4.2 to 72.3)  3.3 (–1.9 to 8.7)  23.9 (–18.0 to 85.1)  9.0 (1.0 to 17.7)
Nonsmoker  32.8 (8.7 to 62.1)  4.4 (0.3 to 8.7)  –1.1 (–18.0 to 19.4)  2.4 (–1.4 to 6.5)
Smoker  0.1 (–30.1 to 43.4)  1.9 (–5.7 to 10.2)  –0.2 (–32.5 to 47.7)  –2.1 (–9.6 to 6.0)
BMI < 30 kg/m2  28.7 (4.5 to 58.5)  4.7 (0.4 to 9.1)  7.0 (–13.2 to 32.0)  3.1 (–1.1 to 7.5)
BMI ≥ 30 kg/m2  12.0 (–18.7 to 54.3)  1.8 (–5.4 to 9.5)  –15.9 (–37.0 to 12.2)  –1.6 (–7.7 to 4.9)
No diabetes  23.6 (2.0 to 49.7)  5.0 (1.0 to 9.2)  –9.4 (–24.2 to 8.4)  0.5 (–3.1 to 4.3)
Diabetes  21.6 (–20.2 to 85.2)  –0.7 (–9.2 to 8.5)  82.6 (1.1 to 230.3)  8.6 (–3.6 to 22.4)
No CHD  24.1 (3.7 to 48.6)  4.2 (0.5 to 8.2)  1.6 (–14.4 to 20.7)  1.6 (–1.9 to 5.2)
CHD  36.9 (–27.5 to 158.5)  3.1 (–10.0 to 18.0)  –52.4 (–86.2 to 63.3)  –2.6 (–20.7 to 19.5)
No medication  25.0 (0.0 to 56.4)  5.6 (1.0 to 10.5)  3.9 (–16.4 to 29.2)  1.3 (–3.1 to 5.8)
Any medicationa  28.3 (–3.0 to 69.8)  2.6 (–3.3 to 8.9)  –10.2 (–31.7 to 18.0)  1.8 (–3.8 to 7.7)
aIncludes statins, NSAIDs, angiotensin-converting enzyme inhibitors, and beta-blockers.Hoffman et al.
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In conclusion, we have shown a weak 
association between long-term PM2.5 exposure 
and systemic inflammatory markers in men, 
which is independent of short-term changes 
in air pollution or temperature. This possi-
bly indicates the induction or sustainment of 
a low-grade systemic inflammatory state by 
chronic PM2.5 exposure. Considering the role 
of these markers as potential mediators in the 
pathogenesis of atherosclerotic disease and 
the known relation between long-term PM 
air pollution and cardiovascular events, this 
result provides a link between long-term PM 
exposure and the hypothesized development 
and progression of atherosclerosis.
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